Repare Therapeutics Inc. (RPTX) DCF Valuation

Repare Therapeutics Inc. (RPTX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Repare Therapeutics Inc. (RPTX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Repare Therapeutics Inc. (RPTX) financial outlook like an expert! This (RPTX) DCF Calculator provides you with pre-filled financial data and total flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .1 7.6 131.8 51.1 68.9 92.8 125.0 168.3 226.7
Revenue Growth, % 0 0 5529.63 1634.61 -61.21 34.7 34.7 34.7 34.7 34.7
EBITDA -25.5 -53.4 -107.2 -17.8 -114.3 -29.4 -39.6 -53.4 -71.9 -96.8
EBITDA, % 100 -39559.26 -1410.38 -13.52 -223.48 -42.7 -42.7 -42.7 -42.7 -42.7
Depreciation 1.0 1.8 3.3 4.2 2.0 34.6 46.6 62.7 84.5 113.8
Depreciation, % 100 1323.7 44 3.17 3.82 50.2 50.2 50.2 50.2 50.2
EBIT -26.5 -55.2 -110.5 -22.0 -116.2 -29.8 -40.2 -54.2 -72.9 -98.3
EBIT, % 100 -40882.96 -1454.38 -16.69 -227.3 -43.34 -43.34 -43.34 -43.34 -43.34
Total Cash 94.8 333.7 341.9 343.9 223.6 68.9 92.8 125.0 168.3 226.7
Total Cash, percent .0 .2 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 3.1 6.2 3.2 4.3 15.3
Account Receivables, % 100 4565.93 42.55 3.28 29.95
Inventories .0 .0 .0 -2.8 .0 13.5 18.2 24.5 32.9 44.4
Inventories, % 100 0 0 -2.13 0 19.57 19.57 19.57 19.57 19.57
Accounts Payable 2.1 2.3 2.3 .5 2.4 32.4 43.7 58.8 79.2 106.7
Accounts Payable, % 100 1667.41 30.29 0.34969 4.69 47.07 47.07 47.07 47.07 47.07
Capital Expenditure -1.3 -2.2 -1.7 -.6 -1.9 -17.4 -23.5 -31.6 -42.6 -57.4
Capital Expenditure, % 100 -1657.04 -22.24 -0.45665 -3.79 -25.3 -25.3 -25.3 -25.3 -25.3
Tax Rate, % 9.09 9.09 9.09 9.09 9.09 9.09 9.09 9.09 9.09 9.09
EBITAT -26.6 -53.9 -108.8 -46.0 -105.7 -29.1 -39.2 -52.7 -71.0 -95.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -27.9 -57.3 -104.2 -42.5 -117.5 -18.1 -22.7 -30.5 -41.1 -55.4
WACC, % 7.62 7.61 7.61 7.62 7.59 7.61 7.61 7.61 7.61 7.61
PV UFCF
SUM PV UFCF -129.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -56
Terminal Value -1,007
Present Terminal Value -698
Enterprise Value -828
Net Debt -108
Equity Value -720
Diluted Shares Outstanding, MM 42
Equity Value Per Share -17.11

What You Will Get

  • Real RPTX Financial Data: Pre-filled with Repare Therapeutics Inc.’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Repare Therapeutics Inc.’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive Data: Repare Therapeutics Inc.'s (RPTX) historical financial reports and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: Observe Repare's intrinsic value recalculating instantly.
  • Intuitive Visual Outputs: Dashboard graphs showcase valuation results and essential metrics.
  • Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Repare Therapeutics data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Repare Therapeutics’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Repare Therapeutics Inc. (RPTX)?

  • Designed for Industry Experts: A sophisticated tool tailored for analysts, investors, and biotech professionals.
  • Comprehensive Data: Repare Therapeutics’ historical and projected financials preloaded for precision.
  • Flexible Scenario Analysis: Easily simulate various forecasts and assumptions to assess different outcomes.
  • Insightful Outputs: Automatically calculates intrinsic value, NPV, and essential financial metrics.
  • User-Friendly Interface: Step-by-step guidance ensures a smooth and efficient calculation process.

Who Should Use This Product?

  • Biotech Students: Explore drug development processes and apply them using real-world data on Repare Therapeutics Inc. (RPTX).
  • Researchers: Integrate cutting-edge models into your studies or publications related to cancer therapies.
  • Investors: Validate your investment strategies and assess the potential of Repare Therapeutics Inc. (RPTX) in the biotech market.
  • Market Analysts: Optimize your analysis with a tailored, user-friendly model for evaluating biotech companies.
  • Healthcare Professionals: Understand how innovative companies like Repare Therapeutics Inc. (RPTX) are assessed in the industry.

What the Template Contains

  • Pre-Filled Data: Includes Repare Therapeutics Inc.'s historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automated calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
  • Key Financial Ratios: Evaluate Repare Therapeutics Inc.'s profitability, efficiency, and leverage.
  • Customizable Inputs: Easily modify revenue growth, profit margins, and tax rates.
  • Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.

Es wurden keine passenden Produkte gefunden.